Guest: Sara Tolaney MD, MPH <br>


  <p>There are several new strategies that have been emerging to treat patients with HER2+ breast cancer, and here to walk us through those that were highlighted at the 2020 ASCO Annual Meeting is Dr. Sara Tolaney, breast medical oncologist at the Dana-Farber Cancer Institute and Assistant Professor of Medicine at the Harvard Medical School.</p>

Guest: Sara Tolaney MD, MPH There are several new strategies that have been emerging to treat patients with HER2+ breast cancer, and here to walk us through those that were highlighted at the 2020 ASCO Annual Meeting is Dr. Sara Tolaney, breast medical oncologist at the Dana-Farber Cancer Institute and Assistant Professor of Medicine at the Harvard Medical School.

New Treatment Strategies for HER2+ Breast Cancer: The Latest from ASCO

Advances in Women’s Health addresses advances, breakthroughs, and treatments for conditions related to women’s health, as well as preventive measures physicians can advise their patients to pursue. Topics will include breast health as it relates to cancer, ethnicity, fertility, and pregnancy; osteoporosis; female athletes’ health and emotional issues; mental health; pregnancy and all facets related to it; aging; nutrition and health; eating disorders; alternative medicine; and sex education.

Share New Treatment Strategies for HER2+ Breast Cancer: The Latest from ASCO

Sign up to save your podcasts

New Treatment Strategies for HER2+ Breast Cancer: The Latest from ASCO

New Treatment Strategies for HER2+ Breast Cancer: The Latest from ASCO

More shows like Advances in Women's Health

Medical Industry Feature

SexMed

Partners in Practice

Second Opinion LIVE!

Medical Breakthroughs from Penn Medicine

GI Insights

Conference Coverage

HOT For Your Health

Up First from NPR

You Are Not Broken

Dr. Streicher’s Inside Information: Menopause, Midlife, and More